Dec 22, 2022 | Gail McCray
Overall: As with every ASH, we are able to witness up close and personal the exciting advances in science and medicine – the research moving us more and more towards precision medicine, the current clinical trials (phases I, II, and III) and the medications approved...
Dec 22, 2022 | Teresa Miceli
Attending the 64th American Society of Hematology (ASH) Annual Meeting, I am continually reminded of how far we have come in the treatment landscape of multiple myeloma (MM) since I became a nurse I 1991. Acronyms of drug regimens that, for the most part, are no...
Dec 16, 2022 | Jack Aiello
PREFACE This is my 17th year attending American Society of Hematology (ASH) Annual Meeting, where typically over 30,000 attendees from all over the world (hematologists/oncologists, lab researchers, oncology nurses, scientists, and 300 pharma companies) attend. This...
Dec 11, 2022 | Linda Huguelet
On Saturday, our team had the distinct privilege to attend the International Myeloma Working Group (IMWG) meeting. This organization includes over 280 myeloma specialists and researchers from all over the world who share the same goal of advancing myeloma research...
Dec 11, 2022 | Jack Aiello
Today, I began at 4 a.m. PST for the privilege of being able to attend the International Myeloma Working Group (IMWG) meeting. The IMWG has more than 260 myeloma specialists who meet twice a year. Whenever you see a phrase such as “…responses per IMWG guidelines,”...
